About Renewal Bio
Renewal Bio is a company based in Herzliya (Israel) founded in 2022 by Vladik Krupalnik, Omri Amirav-Drory, and Ohad Gafni. Renewal Bio offers products and services including Ex utero Embryogenesis Research, Synthetic Embryo Models, and Publication Services. Renewal Bio operates in a competitive market with competitors including NuVasive, Ensoma, Sprout Pharmaceuticals, ObsEva and Hope Medicine, among others.
- Headquarter Herzliya, Israel
- Founders Vladik Krupalnik, Omri Amirav-Drory, Ohad Gafni
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Renewal Bio
Renewal Bio offers a comprehensive portfolio of products and services, including Ex utero Embryogenesis Research, Synthetic Embryo Models, and Publication Services.
Studies mouse embryo development from pre-gastrulation stages.
Generates models of human post-implantation embryos from stem cells.
Shares research papers on embryology in academic journals.
People of Renewal Bio
Unlock access to complete
Leadership Team
2 people
Research Team
2 people
COO Team
1 people
Co Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Renewal Bio
Investors in Renewal Bio
Renewal Bio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include YZi Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in Web3, AI, and biotech is facilitated by YZi Labs.
|
Locked | Locked | Locked |
Investor details for Renewal Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Renewal Bio
Investment portfolio details for Renewal Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Renewal Bio
Detailed financials for Renewal Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Renewal Bio Comparisons
Peer comparison for Renewal Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Renewal Bio
Renewal Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuVasive, Ensoma, Sprout Pharmaceuticals, ObsEva and Hope Medicine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Smart surgical devices for spinal surgery are developed.
|
|
| Locked | Locked | Locked |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool
|
|
| Locked | Locked | Locked |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| Locked | Locked | Locked |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Developer of new fertility treatments for women
|
Detailed competitors of Renewal Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Renewal Bio
Complete news archive for Renewal Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renewal Bio
Renewal Bio was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Renewal Bio is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.
Omri Amirav-Drory is the current CEO of Renewal Bio. They have also founded this company.
Renewal Bio was founded in 2022 in Herzliya, Israel, within the biotechnology sector. Therapies addressing infertility and genetic diseases are developed, alongside a bio platform that integrates biology, hardware, and software. Advancements in lab-grown organs and blood system rejuvenation are targeted through these operations. The companys activities focus on therapeutic innovations for reproductive and hereditary health challenges.
Renewal Bio's top competitors include NuVasive, Ensoma and Sprout Pharmaceuticals.
Renewal Bio offers Ex utero Embryogenesis Research, Synthetic Embryo Models, and Publication Services.
Renewal Bio has 1 investor. Key investors include YZi Labs.